{
    "organizations": [],
    "uuid": "08e9ad9e84eb29381260b2e5d2334fea9b9cc4f1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intercept-sees-ocaliva-net-sales-t/brief-intercept-sees-ocaliva-net-sales-to-fall-in-quarter-ended-march-31-idUSFWN1RH0KP",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Sees Ocaliva Net Sales To Fall In Quarter Ended March 31",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 4 (Reuters) - Intercept Pharmaceuticals Inc:\n* EXPECTS NET SALES OF OCALIVA FOR QUARTER ENDED MARCH 31, TO BE SLIGHTLY LOWER THAN NET SALES OF OCALIVA FOR QUARTER ENDED DEC 31, 2017â€‹ Source text ( bit.ly/2uINGwG ) Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-04-05T04:41:00.000+03:00",
    "crawled": "2018-04-05T17:18:49.015+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "intercept",
        "pharmaceutical",
        "inc",
        "expects",
        "net",
        "sale",
        "ocaliva",
        "quarter",
        "ended",
        "march",
        "slightly",
        "lower",
        "net",
        "sale",
        "ocaliva",
        "quarter",
        "ended",
        "dec",
        "source",
        "text",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}